Browse the full record of transactions filed by 于海生, Director. Insider active across 1 companies, notably 英科医疗. In total, 33 disclosures have been logged. Regulator: AMF. The full history is accessible without signup.
Declarations 33 total
Executives ● Sale百 百普赛斯 7 SZSE 5,900 shares
SZSE:173000009867117900 · 4 Dec 2025
Executives ● Sale百 百普赛斯 7 SZSE 6,300 shares
SZSE:173000009860701820 · 3 Dec 2025
Executives ● Sale百 百普赛斯 11 SZSE 9,300 shares
SZSE:173000009628394560 · 13 Oct 2025
Executives ● Sale百 百普赛斯 11 SZSE 11,800 shares
SZSE:173000009625471900 · 10 Oct 2025
Executives ● Sale九 九洲集团 7 SZSE 20,000 shares
SZSE:173000009171309200 · 7 Jul 2025
Executives ● Sale仙 仙乐健康 7 SZSE 2,100,000 shares
SZSE:173000008295273920 · 25 Nov 2024
Executives ● Purchase仙 仙乐健康 7 SZSE 15,900 shares
SZSE:173000007961467800 · 15 Aug 2024
Ideal exit: 12 May 2025 (T+270) Executives ● Purchase仙 仙乐健康 7 SZSE 6,800 shares
SZSE:173000007956696160 · 14 Aug 2024
Ideal exit: 11 May 2025 (T+270) Executives ● Purchase英 英科医疗 7 SZSE 121,000 shares
SZSE:173000007417101060 · 22 Mar 2024
Ideal exit: 17 Dec 2024 (T+270) Executives ● Purchase九 九洲集团 21 SZSE 181,000 shares
SZSE:173000009655466000 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 21 SZSE 559,200 shares
SZSE:173000009655464600 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 18 SZSE 49,600 shares
SZSE:173000009655462850 · 17 May 2022
Ideal exit: 11 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 18 SZSE 327,000 shares
SZSE:173000009655461470 · 16 May 2022
Ideal exit: 10 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 7 SZSE 362,800 shares
SZSE:173000009655458800 · 13 May 2022
Ideal exit: 7 Feb 2023 (T+270) Executives ● Purchase九 九洲集团 7 SZSE 31,300 shares
SZSE:173000009655453340 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Sale昂 昂立教育 11 SSE 2,000 shares
SSE:173000005220655700 · 13 Jan 2022
Executives ● Sale英 英科医疗 22 SZSE 2,242,050 shares
SZSE:173000005069817150 · 12 Nov 2021
100 shares
SSE:173000004974899000 · 13 Oct 2021
Executives ● Purchase昂 昂立教育 7 SSE 9,400 shares
SSE:173000004974898980 · 11 Oct 2021
Ideal exit: 8 Jul 2022 (T+270) 100 shares
SSE:173000004967629660 · 8 Oct 2021
Executives ● Sale英 英科医疗 7 SZSE 63,000 shares
SZSE:173000004609545250 · 30 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 10,000 shares
SZSE:173000005688670140 · 30 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 547,163 shares
SZSE:173000004609545200 · 29 Jul 2021
Executives ● Sale英 英科医疗 22 SZSE 40,400 shares
SZSE:173000004604146300 · 28 Jul 2021
Executives ● Sale仙 仙乐健康 7 SZSE 7,200 shares
SZSE:173000004629073660 · 20 Jul 2021
25 of 33 declarations
Load more (8 remaining) About 于海生 Yu Haisheng is a director and executive at Yingke Medical. He is involved in the strategic direction of the company and oversees operations to ensure growth objectives are met. His expertise in the healthcare sector enables him to guide the company towards new opportunities.